A new study published in the journal Vaccine shows that receiving a COVID-19 vaccine could reduce the risk of developing long COVID if it’s administered five months before an infection. The findings could help with the formulation of future vaccination strategies as COVID-19 becomes endemic.   [ Read More ]

New research led by investigators at Mass General Brigham suggests vaccination closer to 32 weeks of pregnancy, rather than the current guidelines of between 32 and 36 weeks, will better protect pregnant women’s newborns against respiratory syncytial virus (RSV).   [ Read More ]

A population-based study conducted by researchers from the Republic of Korea found a significantly higher risk of developing autoimmune and autoinflammatory conditions, such as rheumatoid arthritis, lupus, Crohn’s disease and alopecia, among individuals who had COVID-19, with risks particularly elevated for those with severe cases, Delta variant infections and those who were unvaccinated.   [ Read More ]

The same quality content you trust, redesigned with you in mind:  www.bstquarterly.com

(BTG/SERB Pharmaceuticals)

AURLUMYN (iloprost) injection is a prostacyclin mimetic indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. Effectiveness was established in young, healthy adults who suffered frostbite at high altitudes. It is supplied as a 100 mcg per mL single-dose glass vial per carton.   [ Learn More ]

(MERCK)

CAPVAXIVE is a vaccine indicated for 1) active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B in individuals 18 years of age and older, and 2) active immunization for the prevention of pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B in individuals 18 years of age and older. It is supplied in cartons of one single-dose and 10 single-dose prefilled Luer Lock syringe with tip cap, containing one dose of 0.5 mL.   [ Learn More ]

(FRESENIUS KABI)

CISPLATIN injection is indicated in established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and/or radiotherapeutic procedures; in establish combination with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and/or radiotherapeutic procedures; as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cisplatin injection therapy; and as a single agent for patients with transitional cell bladder cancer that is no longer amenable to local treatments, such as surgery and/or radiotherapy. It is supplied in a 50 mL fill in a 100 mL vial, a 100 mL fill in a 100 mL vial and a 200 mL fill in a 200 mL vial.   [ Learn More ]

(FRESENIUS KABI)

FLUOROURACIL injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with adenocarcinoma of the colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma, and pancreatic adenocarcinoma. It is supplied in 10 mL and 20 mL single-dose flip-top vials.   [ Learn More ]

(LONG GROVE PHARMACEUTICALS)

NOREPINEPHRINE IN SODIUM CHLORIDE injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. It is supplied as a clear, colorless sterile solution in 4 mg/250 mL, 8 mg/250 mL and 15 mg/250 mL non-PVC infusions bags with a single function connector system consisting of a port and cap and packaged in 10 bags of individually aluminum foil pouches.   [ Learn More ]

(ENDO INC.)

ADRENALIN (epinephrine in sodium chloride injection) is a non-selective alpha and beta adrenergic agonist indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. It is supplied as a clear, colorless sterile solution in 2 mg, 4 mg, 5 mg, 8 mg and 10 mg single-dose 250 mL non-PVC infusion bags with a single function connector system consisting of a port and cap, packaged individually in aluminum overwrap with an oxygen scavenger in units of 10.   [ Learn More ]

(PFIZER)

PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W and Y in individuals 10 through 25 years of age. It is supplied in a kit that includes a vial of lyophilized MenACWY component, a prefilled syringe containing MenB component and a vial adapter in cartons of one kit, five kits and 10 kits.   [ Learn More ]

(FRESENIUS KABI)

HYDROMORPHONE HYDROCHLORIDE injection is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which the alternate treatments are inadequate. It is supplied in single dose colorless viles with each mL of sterile, aqueous solution containing 1 mg, 2 mg or 4 mg of hydromorphone hydrochloride with 0.2% sodium citrate and 0.2% citrate acid solution.   [ Learn More ]

(BAVARIAN NORDIC INC.)

JYNNEOS is a vaccine indicated for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. It is supplied in a package of 10 single-dose vials.   [ Learn More ]

(BAVARIAN NORDIC INC.)

RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. It is supplied as a single-dose kit containing one vial of freeze-dried vaccine containing a single dose, one disposable prefilled syringe of sterile diluent for reconstitution (1 mL), one small needle for injection (25 guage, 1 inch), and one long needle for reconstitution (21 gauge, 1½ inches).   [ Learn More ]

(EMERGENT TRAVEL HEALTH)

VIVOTIF (typhoid vaccine live oral Ty21A) is indicated for immunization in adults and children greater than 6 years of age against disease caused by Salmonella typhi. It is supplied in a single foil blister containing four doses of vaccine in a single package.   [ Learn More ]

(CUMBERLAND PHARMACEUTICALS)

VIBATIV is a lypoglycopeptide antibacterial drug indicated for the treatment of the following infections in adult patients caused by designated susceptible bacteria: complicated skin and skin structure infections (cSSSI); and hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates Staphylococcus aureaus. It is supplied in individual cartons of 750 mg single-dose vials; cartons of 12 individually packaged 750 mg single-dose vials; and cartons of four individually packaged 750 mg single-dose vials.   [ Learn More ]

(MODERNA)

MRESVIA is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. It is supplied as a single-dose prefilled plastic syringe in a blister pack containing one dose of 0.5 mL, and in a carton of 10 single-dose prefilled plastic syringes, each syringe containing one dose of 0.5 mL. Each carton contains 5 blisters, and each blister contains two syringes.   [ Learn More ]

(INTERNATIONAL MEDICATION SYSTEM)

REGADENOSON injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. It is supplied as a sterile, preservative-free solution containing 0.08 mg/mL regadenoson in single-dose 5 mL prefilled syringes with a luer-lock fitting.   [ Learn More ]

(VALNEVA USA)

IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. It is supplied in a carton containing one single-dose vial of lyophilized antigen component, live, and one prefilled ungraduated syringe of sterile water diluent component (packaged without needles).   [ Learn More ]

(GLAXOSMITHKLINE)

HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b in children aged 6 weeks through 4 years (prior to fifth birthday). HIBERIX vial and vial presentation is supplied in a carton packaged without syringes or needles containing 10 single-dose vials of lyophilized antigen component and 10 single-dose vials of sterile saline diluent. HIBERIX vial and prefilled syringe presentation is supplied in a carton containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated TIP-LOK syringes of sterile saline diluent packaged without needles.   [ Learn More ]

(CSL BEHRING)

ZEMAIRA is an alpha1-proteinase inhibitor (A ₁-PI; human) indicated for chronic augmentation and maintenance therapy in adults with A ₁-PI deficiency and clinical evidence of emphysema. It is supplied in single-dose vials containing 1,000 mg, 4,000 mg or 5,000 mg functionally active A ₁-PI.   [ Learn More ]

(PFIZER-BIONTECH)

COMIRNATY (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 single-dose glass prefilled syringes, single-dose plastic prefilled syringes and single-dose vials.   [ Learn More ]

(NOVAVAX, INC)

The Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit) is a vaccine indicated for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in boxes of 10 doses of 0.5 mL Pre-filled Syringes.   [ Learn More ]

(GLAXOSMITHKLINE)

AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied as two components: a single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles) in cartons of 10 vials.   [ Learn More ]

(PFIZER INC.)

ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiration tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied in a kit that includes a vial of lyophilized antigen component, a prefilled syringe containing sterile water diluent component and a vial adapter in cartons of one, five and 10 kits.   [ Learn More ]

Rates per gram are effective October 1, 2024, through December 31, 2024

* ASP-based Medicare payment rate not yet available; payment rate assigned by your Medicare Administrative Contractor.